Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)
Sponsor: Yonsei University
Terminated
Slow Patient Enrollment
Other terminated trials from Yonsei University
Other Acute Ischemic Stroke trials with similar outcome
Listed as NCT04839224, this PHASE3 trial focuses on Acute Ischemic Stroke and remains terminated or withdrawn. Sponsored by Yonsei University, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Feb 2025 — Sep 2025 [monthly]
Terminated PHASE3
Status: Unknown → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jun 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2021 — Jun 2023 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .